Clinical Trials: Hematological Disorders

Duarte : City of Hope

Hematopoietic Cell Transplantation for Hematological Malignancies: Neuropsychological Function after Hematopoietic Cell Transplantation

Duarte : City of Hope

SGN-35-008 An Open Label Clinical Pharmacology An Open-Label Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35) in Patients With CD30-Positive Hematologic Malignancies: CYP3A4 Drug-Drug Interactions, Excretion, and Special Populations

Columbus : Columbus Center for Women's Health Research

Uterine Fibroids and Anemia

Morgantown : West Virginia University - Clinical Trials Research Unit

WVU011012 - Phase II study of Atorvastatin, micro-dose methotrexate and tacrolimus administered only to transplant recipients for the prophylaxis of acute graft-versus-host disease following matched sibling hematopoietic cell transplantation

Morgantown : West Virginia University - Clinical Trials Research Unit

WVU011012 - Phase II study of Atorvastatin, micro-dose methotrexate and tacrolimus administered only to transplant recipients for the prophylaxis of acute graft-versus-host disease following matched sibling hematopoietic cell transplantation

Morgantown : West Virginia University - Clinical Trials Research Unit

WVU11010 - Phase II study evaluating the safety and efficacy of Atorvastatin for the prophylaxsis of acute graft-versus-host disease in patients undergoing matched sibling hematopoietic stem cell transplantation

Morgantown : West Virginia University - Clinical Trials Research Unit

WVU11310-Once daily intravenous Busulfex as part of reduced toxicity conditioning for patients with relapsed/refractory Hodgkin and non-Hodgkin lymphomas undergoing allogeneic hematopoietic cell transplantation - A multicenter phase II study.